Eandi, .M. 2006. Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer. Farmeconomia. Health economics and therapeutic pathways. 7, 2 (Sep. 2006), 97–117. DOI:https://doi.org/10.7175/fe.v7i2.680.